Another anti‐interleukin ( <scp>IL</scp> )‐17 inhibitor: is there an advantage of blocking <scp>IL‐17A</scp> and <scp>IL‐17F</scp> ?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Another anti‐interleukin ( IL )‐17 inhibitor: is there an advantage of blocking IL‐17A and IL‐17F ?

Published:2022-04 Issue:4 Volume:186 Page:603-604
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Gerdes Sascha¹^ORCID,Albrecht Joerg²³^ORCID

Affiliation:

1. Psoriasis‐Center Kiel, Department of Dermatology University Medical Center Schleswig‐Holstein Campus Kiel Kiel Germany

2. Division of Dermatology, Department of Medicine John H. Stroger, Jr Hospital of Cook County Chicago IL USA

3. Division of Dermatology, Department of Otorhinolaryngology Rush Medical College Chicago IL USA

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20959

Reference7 articles.

1. Bimekizumab for the Treatment of Psoriasis

2. Anti-IL17 therapies for psoriasis

3. Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study

4. Bimekizumab versus Secukinumab in Plaque Psoriasis

5. Recognition of Candida albicans and Role of Innate Type 17 Immunity in Oral Candidiasis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP